05/15/2025 2:13 PM | ARMISTICE CAPITAL, LLC (Filed by) Vincerx Pharma (Subject)
| Form SCHEDULE 13G/A | |
05/12/2025 3:49 PM | Vincerx Pharma (Filer)
| Form DEF 14A | |
05/04/2025 11:15 PM | Vincerx Pharma (Filer)
| Form EFFECT | |
05/04/2025 11:15 PM | Vincerx Pharma (Filer)
| Form EFFECT | |
05/04/2025 11:15 PM | Vincerx Pharma (Filer)
| Form EFFECT | |
05/01/2025 4:06 PM | Vincerx Pharma (Filer)
| Form POS AM | |
05/01/2025 4:07 PM | Vincerx Pharma (Filer)
| Form POS AM | |
05/01/2025 4:08 PM | Vincerx Pharma (Filer)
| Form POS AM | |
05/01/2025 4:10 PM | Vincerx Pharma (Filer)
| Form S-8 POS | |
05/01/2025 4:11 PM | Vincerx Pharma (Filer)
| Form S-8 POS | |
05/01/2025 4:11 PM | Vincerx Pharma (Filer)
| Form S-8 POS | |
Get the Latest News and Ratings for VINC and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Vincerx Pharma and its competitors with MarketBeat's FREE daily newsletter.
|
05/01/2025 4:12 PM | Vincerx Pharma (Filer)
| Form S-8 POS | |
05/01/2025 4:13 PM | Vincerx Pharma (Filer)
| Form S-8 POS | |
04/30/2025 3:41 PM | Vincerx Pharma (Filer)
| Form PRE 14A | |
04/17/2025 3:52 PM | Vincerx Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/11/2025 3:03 PM | Vincerx Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/02/2025 11:15 PM | Vincerx Pharma (Filer)
| Form EFFECT | |
03/31/2025 3:02 PM | Vincerx Pharma (Filer)
| Form S-3/A | |
03/18/2025 8:02 AM | Vincerx Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/18/2025 8:05 AM | Vincerx Pharma (Subject)
| Form 425 | |
02/12/2025 7:30 AM | Prosight Management, LP (Filed by) Vincerx Pharma (Subject)
| Form SCHEDULE 13G/A | |
02/11/2025 6:09 PM | Long Focus Capital Management, LLC (Filed by) Vincerx Pharma (Subject)
| Form SCHEDULE 13G/A | |
02/06/2025 3:05 PM | Vincerx Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/06/2025 3:06 PM | Vincerx Pharma (Filer)
| Form DEFA14A | |
01/29/2025 3:05 PM | Vincerx Pharma (Filer)
| Form DEFA14A | |
01/23/2025 3:10 PM | Vincerx Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/23/2025 3:13 PM | Vincerx Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/23/2025 3:15 PM | Vincerx Pharma (Filer)
| Form DEFA14A | |
01/21/2025 3:31 PM | Vincerx Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/21/2025 3:29 PM | Vincerx Pharma (Filer)
| Form 424B5 | |
01/16/2025 4:11 PM | Vincerx Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/27/2024 3:12 PM | Vincerx Pharma (Filer)
| Form 424B5 | |
12/27/2024 3:13 PM | Vincerx Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/25/2024 4:05 PM | Vincerx Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/14/2024 10:57 AM | BANK OF AMERICA CORP /DE/ (Filed by) Vincerx Pharma (Subject)
| Form SC 13G/A | |
11/13/2024 7:32 AM | Prosight Management, LP (Filed by) Vincerx Pharma (Subject)
| Form SC 13G/A | |
11/05/2024 8:15 AM | Vincerx Pharma (Filer)
| Form PRE 14A | |
09/30/2024 5:57 AM | Vincerx Pharma (Subject)
| Form SC TO-I/A | |
09/10/2024 3:02 PM | Vincerx Pharma (Subject)
| Form SC TO-I/A | |
08/16/2024 3:01 PM | Vincerx Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/14/2024 7:11 PM | THOMAS TOM C (Reporting) Vincerx Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
Massive new energy source found in Utah (Ad) NEW THIS WEEK: Huge Energy Discovery In Utah
The Department of Energy say it could power America for millions of years. And both grizzled oilmen and clean energy supporters love it: Energy Secretary Chris Wright called it "an awesome resource," while Warren Buffett, Jeff Bezos, Mark Zuckerberg, and Bill Gates are all directly invested. Find out what billionaires already know about this new energy source |
08/14/2024 7:00 PM | Izumi Raquel E. (Reporting) Vincerx Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/14/2024 7:03 PM | Seelenberger Alexander A. (Reporting) Vincerx Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/14/2024 7:07 PM | Hamdy Ahmed MD (Reporting) Vincerx Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/08/2024 3:37 PM | Vincerx Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/08/2024 3:39 PM | Vincerx Pharma (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/08/2024 3:45 PM | Vincerx Pharma (Filer)
| Form DEF 14A | |
05/29/2024 7:54 PM | Hamdy Ahmed MD (Reporting) Vincerx Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/29/2024 7:55 PM | THOMAS TOM C (Reporting) Vincerx Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/29/2024 8:03 PM | Izumi Raquel E. (Reporting) Vincerx Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/29/2024 8:12 PM | Seelenberger Alexander A. (Reporting) Vincerx Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/28/2024 3:35 PM | Bushnell Laura I. (Reporting) Vincerx Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/28/2024 3:36 PM | Stevens Ruth E. (Reporting) Vincerx Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/28/2024 3:36 PM | Lee John H. (Reporting) Vincerx Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/28/2024 3:38 PM | Salva Francisco D. (Reporting) Vincerx Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/28/2024 3:40 PM | Druker Brian (Reporting) Vincerx Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/28/2024 3:06 PM | Vincerx Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |